APA (7th ed.) Citation

V, R., DM, D. V., E, R., G, K., X, H., M, P., . . . S, G. (2025). Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer. Journal for immunotherapy of cancer, 13(2), . https://doi.org/10.1136/jitc-2024-010541

Chicago Style (17th ed.) Citation

V, Roudko, et al. "Immunological Biomarkers of Response and Resistance to Treatment with Cabozantinib and Nivolumab in Recurrent Endometrial Cancer." Journal for Immunotherapy of Cancer 13, no. 2 (2025). https://doi.org/10.1136/jitc-2024-010541.

MLA (9th ed.) Citation

V, Roudko, et al. "Immunological Biomarkers of Response and Resistance to Treatment with Cabozantinib and Nivolumab in Recurrent Endometrial Cancer." Journal for Immunotherapy of Cancer, vol. 13, no. 2, 2025, https://doi.org/10.1136/jitc-2024-010541.